BTIG Maintains Buy on Connect Biopharma Hldgs, Lowers Price Target to $5

Benzinga · 3d ago
BTIG analyst Julian Harrison maintains Connect Biopharma Hldgs (NASDAQ:CNTB) with a Buy and lowers the price target from $10 to $5.